The t(4;14)(p16;q32) translocation, found in more than 20% of multiple myeloma cases, generates a novel IGH-NSD2 hybrid transcript, resulting in marked upregulation of NSD2 expression and activity [61,101]. Here, NSD2 is linked to plasma cell myeloma.